help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nørrelund, H.
Right arrow Articles by Flyvbjerg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nørrelund, H.
Right arrow Articles by Flyvbjerg, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 7 3292-3298
Copyright © 2003 by The Endocrine Society

The Effect of Growth Hormone on the Insulin-Like Growth Factor System during Fasting

Helene Nørrelund, Jan Frystyk, Jens Otto Lunde Jørgensen, Niels Møller, Jens Sandahl Christiansen, Hans Ørskov and Allan Flyvbjerg

Medical Department M (Endocrinology and Diabetes) (H.N., J.O.L.J., N.M., J.S.C., A.F.), Aarhus Kommunehospital, and Medical Research Laboratories (J.F., N.M., H.O., A.F.), Institute of Experimental Clinical Research, Aarhus University, DK-8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Helene Nørrelund, M.D., Ph.D., Medical Department M, Aarhus Kommunehospital, DK-8000 Aarhus C, Denmark. E-mail: helenenorrelund{at}dadlnet.dk.

The present study investigates the possible stimulatory effect of endogenous GH on IGF and IGF-binding protein (IGFBP) levels during fasting. Eight normal subjects were examined on four occasions: 1) in the basal postabsorptive state; 2) after 40 h of fasting; 3) after 40 h of fasting with somatostatin suppression of GH; and 4) after 40 h of fasting with suppression of GH and exogenous GH replacement. The two somatostatin experiments were identical in terms of hormone replacement (except for GH). Short-term fasting led to a 50% reduction in free IGF-I. The reduction in free IGF-I was paralleled by an increase in IGFBP-1, an increase in the complex formation of IGFBP-1 and IGF-I, and a modest reduction in IGFBP-3 proteolysis. GH deprivation during fasting led to a 35% reduction in total IGF-I and a 70% reduction in free IGF-I. GH replacement increased free and total IGF-I to levels similar to those observed during plain fasting and decreased IGFBP-1, however, without affecting IGFBP-1-bound IGF-I. Finally, IGFBP-3 proteolysis was slightly increased by GH replacement. In conclusion, the major new finding of the present study is that the GH hypersecretion seen during short-term fasting is not merely secondary to a reduction in IGF bioactivity.

This work was supported by the Danish Research Council Grant 9600822 (Aarhus University–Novo Nordisk Centre for Research in Growth and Regeneration) and Grants 9700592 and 22020141; the Eva and Henry Frænkels Memorial Foundation; and the Hørslev Foundation.

Abbreviations: IGFBP, IGF-specific binding protein; IRMA, immunoradiometric assay; rh, recombinant human; tIGF, total IGF; WIB, Western immunoblotting; WLB, Western ligand blotting.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. Moller, L. Dalman, H. Norrelund, N. Billestrup, J. Frystyk, N. Moller, and J. O. L. Jorgensen
Impact of Fasting on Growth Hormone Signaling and Action in Muscle and Fat
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 965 - 972.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A. Alemany, B. C. Nindl, M. D. Kellogg, W. J. Tharion, A. J. Young, and S. J. Montain
Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity
J Appl Physiol, July 1, 2008; 105(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. K. Stoving, J.-W. Chen, D. Glintborg, K. Brixen, A. Flyvbjerg, K. Horder, and J. Frystyk
Bioactive Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-1 in Anorexia Nervosa
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2323 - 2329.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Abe, T. Matsunaga, K. Kameda, H. Tomita, T. Fujiwara, H. Ishizaka, H. Hanada, K. Fukui, I. Fukuda, T. Osanai, et al.
Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1387 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski
Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight
J. Nutr., July 1, 2005; 135(7): 1667 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society